PE20080065A1 - Compuestos derivados de bencimidazol como moduladores del receptor vainilloide vr1 - Google Patents
Compuestos derivados de bencimidazol como moduladores del receptor vainilloide vr1Info
- Publication number
- PE20080065A1 PE20080065A1 PE2007000543A PE2007000543A PE20080065A1 PE 20080065 A1 PE20080065 A1 PE 20080065A1 PE 2007000543 A PE2007000543 A PE 2007000543A PE 2007000543 A PE2007000543 A PE 2007000543A PE 20080065 A1 PE20080065 A1 PE 20080065A1
- Authority
- PE
- Peru
- Prior art keywords
- phenyl
- alkyl
- benzimidazole
- vainilloid
- modulators
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical class 0.000 abstract 3
- 229920002554 vinyl polymer Polymers 0.000 abstract 3
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 2
- 208000002193 Pain Diseases 0.000 abstract 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 abstract 2
- -1 BENZIMIDAZOLE DERIVATIVE COMPOUNDS Chemical class 0.000 abstract 1
- 208000000094 Chronic Pain Diseases 0.000 abstract 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 abstract 1
- XIPUIGPNIDKXJU-UHFFFAOYSA-N [CH]1CC1 Chemical class [CH]1CC1 XIPUIGPNIDKXJU-UHFFFAOYSA-N 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 208000005298 acute pain Diseases 0.000 abstract 1
- 235000010290 biphenyl Nutrition 0.000 abstract 1
- 239000004305 biphenyl Substances 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- CFHIDWOYWUOIHU-UHFFFAOYSA-N oxomethyl Chemical compound O=[CH] CFHIDWOYWUOIHU-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
SE REFIERE A COMPUESTOS DERIVADOS DE BENCIMIDAZOL DE FORMULA (I) DONDE LAS LINEAS PUNTEADAS ENTRE LAS POSICIONES 1, 2 Y 3 SON UN DOBLE ENLACE TAUTOMERICO; p ES 1 O 2; q ES 0 O 1; r ES DE 0 A 3; L ES ALQUILO(C1-C3), ALQUENILO(C2-C3), ALQUINILO(C2-C3) O CICLOPROPILO; A1 ES FENILO, BIFENILO, NAFTILO, INDOL, ENTRE OTROS; R1 ES OH, CN, HALOGENO, FORMILO, ALCOXI(C1-C6), ENTRE OTROS; R2 ES HALOGENO, ALQUILO(C1-C4), ALCOXI(C1-C4), NITRO, ENTRE OTROS; R3a Y R3b SON CADA UNO H O ALQUILO(C1-C4) OPCIONALMENTE PERFLUORADO; R4 ES HALOGENO, NITRO, CN, ALQUILO(C1-C6), ENTRE OTROS. SON COMPUESTOS PREFERIDOS: (E)-1-(2-{2-[2-(4-TER-BUTIL-FENIL)-VINIL]-1H-BENCIMIDAZOL-5-IL}-FENIL)-ETANONA, (E)-1-(2-{2-[2-(4-TER-BUTIL-FENIL)-VINIL]-1H-BENCIMIDAZOL-5-IL}-FENIL)-ETANOL, (E)-2-{2-[2-(4-TER-BUTIL-FENIL)-VINIL]-1H-BENCIMIDAZOL-5-IL}-FENOL, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA Y A UN PROCEDIMIENTO DE PREPARACION. DICHOS COMPUESTOS SON MODULADORES DEL RECEPTOR VAINILLOIDE VR1 SIENDO UTILES EN EL TRATAMIENTO DEL DOLOR CRONICO O AGUDO
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79750406P | 2006-05-03 | 2006-05-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20080065A1 true PE20080065A1 (es) | 2008-02-25 |
Family
ID=38566108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2007000543A PE20080065A1 (es) | 2006-05-03 | 2007-05-02 | Compuestos derivados de bencimidazol como moduladores del receptor vainilloide vr1 |
Country Status (36)
| Country | Link |
|---|---|
| US (3) | US7951829B2 (es) |
| EP (1) | EP2021330B1 (es) |
| JP (1) | JP5302884B2 (es) |
| KR (1) | KR101434883B1 (es) |
| CN (1) | CN101511797B (es) |
| AR (1) | AR060840A1 (es) |
| AT (1) | ATE482201T1 (es) |
| AU (1) | AU2007248341C1 (es) |
| BR (1) | BRPI0709803B8 (es) |
| CA (1) | CA2651128C (es) |
| CO (1) | CO6160329A2 (es) |
| CR (1) | CR10479A (es) |
| CY (1) | CY1111269T1 (es) |
| DE (1) | DE602007009378D1 (es) |
| DK (1) | DK2021330T3 (es) |
| EA (1) | EA019386B1 (es) |
| EC (1) | ECSP088854A (es) |
| ES (1) | ES2350959T3 (es) |
| HR (1) | HRP20100700T1 (es) |
| IL (1) | IL194916A (es) |
| JO (1) | JO3602B1 (es) |
| MX (1) | MX2008014108A (es) |
| MY (1) | MY154595A (es) |
| NI (1) | NI200800290A (es) |
| NO (1) | NO341965B1 (es) |
| NZ (1) | NZ572251A (es) |
| PE (1) | PE20080065A1 (es) |
| PL (1) | PL2021330T3 (es) |
| PT (1) | PT2021330E (es) |
| RS (1) | RS51473B (es) |
| SI (1) | SI2021330T1 (es) |
| TW (1) | TWI419882B (es) |
| UA (1) | UA94749C2 (es) |
| UY (1) | UY30322A1 (es) |
| WO (1) | WO2007130780A2 (es) |
| ZA (1) | ZA200810234B (es) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0721169A2 (pt) * | 2006-12-15 | 2014-03-18 | Janssen Pharmaceutica Nv | Inibidores de benzimidazol trpv1 |
| US20090092574A1 (en) | 2006-12-29 | 2009-04-09 | Scott Richard W | Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof |
| WO2009079000A1 (en) * | 2007-12-17 | 2009-06-25 | Janssen Pharmaceutica N.V. | Imidazolopyrimidine modulators of trpv1 |
| WO2009078999A1 (en) | 2007-12-17 | 2009-06-25 | Janssen Pharmaceutica N.V. | Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1 |
| US8362012B2 (en) * | 2008-04-18 | 2013-01-29 | Daewoong Pharmaceutical Co., Ltd. | Benzoxazine benzimidazole derivative, a pharmaceutical composition comprising the same, and a use thereof |
| US8232409B2 (en) | 2008-10-15 | 2012-07-31 | Janssen Pharmaceutica N.V. | Heterocyclic benzimidazoles as TRPM8 modulators |
| US8217060B2 (en) * | 2009-05-15 | 2012-07-10 | Janssen Pharmaceutica, Nv | Benzimidazole derivatives useful as TRP M8 receptor modulators |
| US8323805B2 (en) * | 2009-06-04 | 2012-12-04 | Nitto Denko Corporation | Emissive aryl-heteroaryl acetylenes |
| CN102002010A (zh) * | 2009-08-31 | 2011-04-06 | 住友化学株式会社 | 双噁唑啉基烷烃化合物的精制方法 |
| AU2012255935B2 (en) | 2011-05-16 | 2016-06-23 | Innovation Pharmaceuticals Inc. | Compounds for use in treatment of mucositis |
| US9056874B2 (en) | 2012-05-04 | 2015-06-16 | Novartis Ag | Complement pathway modulators and uses thereof |
| CN105229003B (zh) | 2013-03-14 | 2017-03-15 | 诺华股份有限公司 | 作为补体因子b抑制剂用于治疗眼科疾病的2‑(1h‑吲哚‑4‑基甲基)‑3h‑咪唑并[4,5‑b]吡啶‑6‑甲腈衍生物 |
| MX366875B (es) | 2013-07-11 | 2019-07-29 | Bristol Myers Squibb Co | Inhibidores de indoleamina 2,3-dioxigenasa (ido). |
| EP3089963A1 (en) | 2013-10-30 | 2016-11-09 | Novartis AG | 2-benzyl-benzimidazole complement factor b inhibitors and uses thereof |
| EP3348554B1 (en) * | 2015-09-08 | 2020-05-06 | Sumitomo Chemical Company, Limited | Method for producing triazole compound |
| CA3041332A1 (en) * | 2016-11-01 | 2018-05-11 | Merck Sharp & Dohme Corp. | Substituted bicyclic heteroaryl allosteric modulators of nicotinic acetylcholine receptors |
| AU2019262169B2 (en) * | 2018-05-03 | 2024-05-02 | Jiangsu Hengrui Medicine Co., Ltd. | Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORy) and pharmaceutical uses thereof |
| CN108997398B (zh) * | 2018-07-23 | 2020-12-15 | 被忽略疾病药物研发组织 | 一种3,3-二甲基苯并[c][1,2]氧杂戊硼烷-1(3h)-醇的制备方法 |
| CN112745268B (zh) * | 2019-10-31 | 2022-09-16 | 江苏恒瑞医药股份有限公司 | 苯并咪唑衍生物的晶型及制备方法 |
| AU2020377114A1 (en) * | 2019-10-31 | 2022-06-16 | Jiangsu Hengrui Medicine Co., Ltd. | Acid addition salt of RORγ regulator |
| WO2021248008A1 (en) | 2020-06-05 | 2021-12-09 | Innovation Pharmaceuticals Inc. | Arylamide compounds for treatment and prevention of viral infections |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5612360A (en) * | 1992-06-03 | 1997-03-18 | Eli Lilly And Company | Angiotensin II antagonists |
| US6299796B1 (en) | 1997-12-18 | 2001-10-09 | Fuji Photo Film Co., Ltd. | Styryl compound, method for the preparation thereof and electroluminescent element employing the same |
| US6748803B1 (en) * | 2000-02-22 | 2004-06-15 | Simmonds Precison Products, Inc. | Liquid measurement system and shared interface apparatus for use therein |
| WO2004035549A1 (en) * | 2002-10-17 | 2004-04-29 | Amgen Inc. | Benzimidazole derivatives and their use as vanilloid receptor ligands |
| US7135493B2 (en) * | 2003-01-13 | 2006-11-14 | Astellas Pharma Inc. | HDAC inhibitor |
| HRP20060041B1 (hr) * | 2003-07-28 | 2014-06-06 | Janssen Pharmaceutica N.V. | Derivati benzoimidazola, benzotiazola i benzooksazola i njihova uporaba kao modulatora lta4h |
| US7309716B2 (en) * | 2003-10-28 | 2007-12-18 | Vertex Pharmaceuticals Incorporated | Benzimidazoles useful as modulators of ion channels |
| WO2006058338A2 (en) * | 2004-11-29 | 2006-06-01 | Janssen Pharmaceutica N.V. | 4 - piperidinecarboxamide derivatives as modulators of vanilloid vr1 receptor |
| PL2081572T3 (pl) * | 2006-07-04 | 2010-07-30 | Janssen Pharmaceutica Nv | Benzimidazolowe związki antagonistyczne wobec receptora kannabinoidowego zawierające podstawioną grupę heterocykliczną |
| BRPI0721169A2 (pt) * | 2006-12-15 | 2014-03-18 | Janssen Pharmaceutica Nv | Inibidores de benzimidazol trpv1 |
-
2007
- 2007-04-13 US US11/734,984 patent/US7951829B2/en active Active
- 2007-04-17 BR BRPI0709803A patent/BRPI0709803B8/pt active IP Right Grant
- 2007-04-17 MX MX2008014108A patent/MX2008014108A/es active IP Right Grant
- 2007-04-17 EA EA200870497A patent/EA019386B1/ru unknown
- 2007-04-17 PL PL07760746T patent/PL2021330T3/pl unknown
- 2007-04-17 SI SI200730410T patent/SI2021330T1/sl unknown
- 2007-04-17 JP JP2009509920A patent/JP5302884B2/ja active Active
- 2007-04-17 DE DE602007009378T patent/DE602007009378D1/de active Active
- 2007-04-17 NZ NZ572251A patent/NZ572251A/xx unknown
- 2007-04-17 HR HR20100700T patent/HRP20100700T1/hr unknown
- 2007-04-17 AT AT07760746T patent/ATE482201T1/de active
- 2007-04-17 WO PCT/US2007/066748 patent/WO2007130780A2/en not_active Ceased
- 2007-04-17 UA UAA200813889A patent/UA94749C2/ru unknown
- 2007-04-17 EP EP07760746A patent/EP2021330B1/en active Active
- 2007-04-17 DK DK07760746.3T patent/DK2021330T3/da active
- 2007-04-17 KR KR1020087029196A patent/KR101434883B1/ko active Active
- 2007-04-17 PT PT07760746T patent/PT2021330E/pt unknown
- 2007-04-17 RS RSP-2010/0493A patent/RS51473B/sr unknown
- 2007-04-17 AU AU2007248341A patent/AU2007248341C1/en active Active
- 2007-04-17 ES ES07760746T patent/ES2350959T3/es active Active
- 2007-04-17 CN CN2007800247619A patent/CN101511797B/zh active Active
- 2007-04-17 CA CA2651128A patent/CA2651128C/en active Active
- 2007-04-25 JO JOP/2007/0165A patent/JO3602B1/ar active
- 2007-05-02 AR ARP070101901A patent/AR060840A1/es active IP Right Grant
- 2007-05-02 PE PE2007000543A patent/PE20080065A1/es active IP Right Grant
- 2007-05-02 TW TW096115519A patent/TWI419882B/zh active
- 2007-05-03 UY UY30322A patent/UY30322A1/es not_active Application Discontinuation
-
2008
- 2008-10-26 IL IL194916A patent/IL194916A/en active IP Right Grant
- 2008-10-29 CO CO08115664A patent/CO6160329A2/es unknown
- 2008-10-30 MY MYPI20084339A patent/MY154595A/en unknown
- 2008-10-31 EC EC2008008854A patent/ECSP088854A/es unknown
- 2008-11-03 NI NI200800290A patent/NI200800290A/es unknown
- 2008-12-02 ZA ZA2008/10234A patent/ZA200810234B/en unknown
- 2008-12-02 NO NO20085031A patent/NO341965B1/no unknown
- 2008-12-03 CR CR10479A patent/CR10479A/es not_active Application Discontinuation
-
2010
- 2010-12-17 CY CY20101101167T patent/CY1111269T1/el unknown
-
2011
- 2011-04-12 US US13/084,718 patent/US20110190364A1/en not_active Abandoned
- 2011-04-12 US US13/084,705 patent/US20110190344A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20080065A1 (es) | Compuestos derivados de bencimidazol como moduladores del receptor vainilloide vr1 | |
| PE20141203A1 (es) | Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas | |
| PE20051173A1 (es) | Compuestos azabiciclico (3.1.0) hexanos como moduladores de receptores de dopamina d3 | |
| PE20121088A1 (es) | Nuevos compuestos eficaces como inhibidores de la xantina-oxidasa, metodo para la preparacion de los mismos y composicion farmaceutica que los contiene | |
| PE20080948A1 (es) | Derivados de imidazol como moduladores de la senda de hedgehog | |
| PE20091724A1 (es) | Derivados de indol como moduladores del receptor nicotinico de acetilcolina alfa 7 | |
| PE20121050A1 (es) | Compuestos de n-(1-(4-(1h-pirazol-5-il)ftalazin-1-il)piperidin-4-il)-benzamida sustituidos como antagonistas de la trayectoria hedgehog | |
| PE20061150A1 (es) | Derivados de n-(n-sulfonilaminoarilmetil)ciclopropanocarboxamida sustituidos como antagonistas del receptor vainilloide tipo 1 (vdr1) | |
| PE20142019A1 (es) | Nuevos derivados de acidos indaniloxidihidrobenzofuranilaceticos y sus usos como agonistas del receptor gpr40 | |
| PE20120620A1 (es) | Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasas | |
| PE20140207A1 (es) | Composiciones y metodos para modular el fxr | |
| PE20141375A1 (es) | Activadores de glucoquinasa | |
| PE20091204A1 (es) | Derivados de 2-aminoquinolina como antagonistas del receptor de 5-ht5a | |
| PE20130311A1 (es) | Composiciones y metodos para modular la via de senalizacion de wnt | |
| PE20081454A1 (es) | Derivados de pirazol como moduladores del receptor 5-ht2a de serotonina utiles para el tratamiento de los transtornos relacionados con dicho receptor | |
| PE20081845A1 (es) | Nuevos derivados de aminopirimidina como inhibidores de plk1 | |
| PE20141682A1 (es) | Derivados de (4-fenilimidazol-2-il) etilamina utiles como moduladores de canal de sodio | |
| PE20110875A1 (es) | Derivados de isoindol como inhibidores de bace | |
| PE20090622A1 (es) | Nuevos derivados de bencimidazol sustituido | |
| PE20061298A1 (es) | Compuestos derivados de dihidrobenzofurano como agonistas del receptor de serotonina 5-ht2c | |
| PE20080552A1 (es) | Derivados de alcoholes 1-fenil-2-piridinil alquilenicos como inhibidores de fosfodiesterasa | |
| AR062111A1 (es) | Derivados de beta-d-glucopiranosil indol, metodo de preparacion, composiciones farmaceuticas que los contienen y usos como agentes antidiabeticos. | |
| PE20091222A1 (es) | Bifenilo sustituidos como moduladores del receptor gpra40 | |
| PE20091096A1 (es) | Compuestos organicos | |
| PE20060937A1 (es) | Derivados de sulfonilbencimidazol como agonistas del receptor cannabinoide 2 (cb2) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |